Hanx Biopharmaceuticals to Review 1H26 Interim Results at 17 Aug 2026 Board Meeting

Bulletin Express08-05

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. has scheduled a board meeting for Monday, 17 August 2026. The agenda includes consideration and approval of the consolidated interim results for the six months ended 30 June 2026 and authorization of their subsequent publication. Additional routine corporate matters will also be addressed during the session.

The board currently consists of nine directors: • Executive Directors: Dr. Zhang Faming (Chairman), Dr. Henry Qixiang Li, Ms. Xiao Jieyu, and Mr. Liu Min • Non-Executive Director: Dr. Li Jian • Independent Non-Executive Directors: Dr. Bi Honggang, Mr. Chen Qifeng, Mr. Wong Sai Hung, and Dr. Zhang Qiongguang

The notice was issued in Hong Kong on 5 August 2026 and signed by Chairman and Executive Director Dr. Zhang Faming.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1187738709?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 16:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187738709","market":"us","top_or_hot":-1,"title":"Hanx Biopharmaceuticals to Review 1H26 Interim Results at 17 Aug 2026 Board Meeting","media":"Bulletin Express","content":"<p>Hanx Biopharmaceuticals (Wuhan) Co., Ltd. has scheduled a board meeting for Monday, 17 August 2026. The agenda includes consideration and approval of the consolidated interim results for the six months ended 30 June 2026 and authorization of their subsequent publication. Additional routine corporate matters will also be addressed during the session.</p>\n<p>The board currently consists of nine directors:\n• Executive Directors: Dr. Zhang Faming (Chairman), Dr. Henry Qixiang Li, Ms. Xiao Jieyu, and Mr. Liu Min  \n• Non-Executive Director: Dr. Li Jian  \n• Independent Non-Executive Directors: Dr. Bi Honggang, Mr. Chen Qifeng, Mr. Wong Sai Hung, and Dr. Zhang Qiongguang</p>\n<p>The notice was issued in Hong Kong on 5 August 2026 and signed by Chairman and Executive Director Dr. Zhang Faming.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hanx Biopharmaceuticals to Review 1H26 Interim Results at 17 Aug 2026 Board Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHanx Biopharmaceuticals to Review 1H26 Interim Results at 17 Aug 2026 Board Meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-05 16:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hanx Biopharmaceuticals (Wuhan) Co., Ltd. has scheduled a board meeting for Monday, 17 August 2026. The agenda includes consideration and approval of the consolidated interim results for the six months ended 30 June 2026 and authorization of their subsequent publication. Additional routine corporate matters will also be addressed during the session.</p>\n<p>The board currently consists of nine directors:\n• Executive Directors: Dr. Zhang Faming (Chairman), Dr. Henry Qixiang Li, Ms. Xiao Jieyu, and Mr. Liu Min  \n• Non-Executive Director: Dr. Li Jian  \n• Independent Non-Executive Directors: Dr. Bi Honggang, Mr. Chen Qifeng, Mr. Wong Sai Hung, and Dr. Zhang Qiongguang</p>\n<p>The notice was issued in Hong Kong on 5 August 2026 and signed by Chairman and Executive Director Dr. Zhang Faming.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03378","symbol_name":"翰思艾泰-B","start_time":0,"source_url":"","article_id":"1187738709","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187738709","pubTimestamp":1785920265,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. has scheduled a board meeting for Monday, 17 August 2026. The agenda includes consideration and approval of the consolidated interim results for the six...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03378":"翰思艾泰-B"},"translate_title":"汉克斯生物制药将于 2026 年 8 月 17 日董事会会议上审查 26 年上半年中期业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03378":1},"content_text":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. has scheduled a board meeting for Monday, 17 August 2026. The agenda includes consideration and approval of the consolidated interim results for the six months ended 30 June 2026 and authorization of their subsequent publication. Additional routine corporate matters will also be addressed during the session.\nThe board currently consists of nine directors:\n• Executive Directors: Dr. Zhang Faming (Chairman), Dr. Henry Qixiang Li, Ms. Xiao Jieyu, and Mr. Liu Min  \n• Non-Executive Director: Dr. Li Jian  \n• Independent Non-Executive Directors: Dr. Bi Honggang, Mr. Chen Qifeng, Mr. Wong Sai Hung, and Dr. Zhang Qiongguang\nThe notice was issued in Hong Kong on 5 August 2026 and signed by Chairman and Executive Director Dr. Zhang Faming.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1187738709","isCrawlerRequest":true}